Advanced company searchLink opens in new window

ENVISION PHARMA GROUP LIMITED

Company number 10117262

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
29 Oct 2024 AP01 Appointment of Mr. Adam Brent Deutsch as a director on 20 August 2024
10 Sep 2024 AA Audit exemption subsidiary accounts made up to 31 December 2023
10 Sep 2024 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/23
10 Sep 2024 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/23
10 Sep 2024 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/23
29 Jul 2024 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
24 Jul 2024 SH01 Statement of capital following an allotment of shares on 9 July 2024
  • USD 155,645,159.9034
17 Apr 2024 CS01 Confirmation statement made on 10 April 2024 with no updates
12 Apr 2024 PSC05 Change of details for Evidence Midco Limited as a person with significant control on 4 November 2020
11 Apr 2024 PSC05 Change of details for Evidence Midco Limited as a person with significant control on 22 June 2022
27 Sep 2023 AP01 Appointment of Mr Howard Collins Miller Iii as a director on 12 September 2023
26 Sep 2023 TM01 Termination of appointment of Margaret Heim as a director on 2 August 2023
26 Sep 2023 AA Audit exemption subsidiary accounts made up to 31 December 2022
26 Sep 2023 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/22
26 Sep 2023 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/22
26 Sep 2023 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/22
10 May 2023 SH19 Statement of capital on 10 May 2023
  • USD 155,644,995.1180
10 May 2023 SH20 Statement by Directors
10 May 2023 CAP-SS Solvency Statement dated 09/05/23
10 May 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share prem a/c 09/05/2023
21 Apr 2023 CS01 Confirmation statement made on 10 April 2023 with updates
12 Apr 2023 RP04SH01 Second filing of a statement of capital following an allotment of shares on 6 February 2023
  • USD 155,644,995.1180
22 Mar 2023 AP01 Appointment of Mrs Margaret Heim as a director on 21 February 2023
17 Mar 2023 SH01 Statement of capital following an allotment of shares on 6 February 2023
  • USD 155,645,159.8034
  • ANNOTATION Clarification a second filed SH01 was registered on 12/04/2023.
21 Sep 2022 AA Audit exemption subsidiary accounts made up to 31 December 2021